+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Controlled Release Cardiovascular Therapeutics - Product Thumbnail Image

Controlled Release Cardiovascular Therapeutics

  • Report
  • May 2022
  • 93 Pages
  • Global
From
Hereditary Angioedema Therapeutics Market Size, Share & Trends Analysis Report By Treatment (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor), By Route of Administration, By End Use, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Market Size, Share & Trends Analysis Report By Treatment (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor), By Route of Administration, By End Use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 100 Pages
  • Global
From
Edema Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Participant (Pediatrics, Adults), Study Design (Interventional Trials, Observational Trials), Type (Systemic Edema, Localized Edema), Region, and Segment Forecasts, 2023-2030 - Product Thumbnail Image

Edema Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Participant (Pediatrics, Adults), Study Design (Interventional Trials, Observational Trials), Type (Systemic Edema, Localized Edema), Region, and Segment Forecasts, 2023-2030

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report by Drug Class, by Type (Branded, Generics), by Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), by Region, and Segment Forecasts, 2022-2030 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report by Drug Class, by Type (Branded, Generics), by Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), by Region, and Segment Forecasts, 2022-2030

  • Report
  • January 2022
  • 150 Pages
  • Global
From
Anti-Vascular Endothelial Growth Factor Therapeutics Market Size, Share & Trends Analysis Report By Product (Eylea, Beovu), By Disease (Diabetic Retinopathy, AMD), By Region (APAC, North America), And Segment Forecasts, 2021 - 2028 - Product Thumbnail Image

Anti-Vascular Endothelial Growth Factor Therapeutics Market Size, Share & Trends Analysis Report By Product (Eylea, Beovu), By Disease (Diabetic Retinopathy, AMD), By Region (APAC, North America), And Segment Forecasts, 2021 - 2028

  • Report
  • September 2021
  • 105 Pages
  • Global
From
Pulmonary Arterial Hypertension Market: Analysis By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market: Analysis By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028

  • Report
  • May 2023
  • 190 Pages
  • Global
From
Arteriovenous Fistula Devices Market Size, Share & Trends Analysis Report By Type (AVF Creation Devices, AVF Monitoring Devices, AVF Maintenance Devices), By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Arteriovenous Fistula Devices Market Size, Share & Trends Analysis Report By Type (AVF Creation Devices, AVF Monitoring Devices, AVF Maintenance Devices), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • July 2023
  • 100 Pages
  • Global
From
Disease Analysis: Pulmonary Hypertension - Product Thumbnail Image

Disease Analysis: Pulmonary Hypertension

  • Drug Pipelines
  • April 2021
  • 78 Pages
  • Global
Finerenone - Product Thumbnail Image

Finerenone

  • Report
  • February 2019
  • 19 Pages
  • Global
From
Tyvaso - Product Thumbnail Image

Tyvaso

  • Report
  • October 2018
  • 17 Pages
  • Global
From
Opsumit - Product Thumbnail Image

Opsumit

  • Report
  • October 2018
  • 19 Pages
  • Global
From
Adempas - Product Thumbnail Image

Adempas

  • Report
  • October 2018
  • 20 Pages
  • Global
From
INOpulse - Product Thumbnail Image

INOpulse

  • Report
  • October 2018
  • 17 Pages
  • Global
From
Letairis - Product Thumbnail Image

Letairis

  • Report
  • October 2018
  • 16 Pages
  • Global
From
Plavix - Product Thumbnail Image

Plavix

  • Report
  • July 2018
  • 27 Pages
  • Global
From
Activase - Product Thumbnail Image

Activase

  • Report
  • July 2018
  • 14 Pages
  • Global
From
Kynamro - Product Thumbnail Image

Kynamro

  • Report
  • June 2018
  • 15 Pages
  • Global
From
Lovaza - Product Thumbnail Image

Lovaza

  • Report
  • June 2018
  • 11 Pages
  • Global
From
Drug Overview: Simdax - Product Thumbnail Image

Drug Overview: Simdax

  • Report
  • February 2018
  • 15 Pages
  • Global
From
Drug Analysis: Simdax - Product Thumbnail Image

Drug Analysis: Simdax

  • Drug Pipelines
  • February 2018
  • 15 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more